EUVIMEDEUVIMED entdecken
Multizentrische Studie

Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Hypertension

Giuseppe Derosa, Angela D'Angelo, Leonardina Ciccarelli, Mario N Piccinni, Fabio Pricolo, Sibilla Salvadeo, Lorenza Montagna, Alessia Gravina, Ilaria Ferrari, Simona Galli, Sonia Paniga, Carmine Tinelli und 1 weitere

Endothelium · 2006-01 · 13 (3) · 227-231

DOI: 10.1080/10623320600780942 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Endothelium, online erschienen am 13.07.2009. Verfasst von Giuseppe Derosa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. giuderosa@tin.it. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are conflicting data in the literature regarding the expression pattern of the vascular matrix metalloproteinase (MMP) system and their inhibitors (TIMPs) in human hypertension. The authors hypothesized that MMP-2, MMP-9, and TIMP-1 would be abnormal in hypertension, reflecting alterations in extracellular matrix (ECM) turnover. The authors measured plasma levels and activities of MMP-2, MMP-9, and TIMP-1 in 44 hypertensive patients and 44 controls. MMP-2 levels and activity were significantly higher in hypertensive group (p < .0001). Significant increase was also observed for MMP-9 level and activity (p < .0001) and for TIMP-1 (p < .0001) in hypertensive patients. Plasma levels and activities of MMP-2, MMP-9, and TIMP-1 are increased in hypertensive patients, which may reflect abnormal ECM metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultBlood GlucoseBlood Pressure DeterminationCase-Control StudiesFemaleFibrinolysisHumansHypertensionInflammationLipidsMaleMatrix Metalloproteinase 2Matrix Metalloproteinase 9Middle AgedPlasminogen Activator Inhibitor 1Tissue Inhibitor of Metalloproteinase-1

Substanzen

Blood GlucoseLipidsPlasminogen Activator Inhibitor 1SERPINE1 protein, humanTissue Inhibitor of Metalloproteinase-1Matrix Metalloproteinase 2Matrix Metalloproteinase 9

Autor:innen und Institutionen

  • Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. giuderosa@tin.it

Zitieren

APA

Derosa, G., D'Angelo, A., Ciccarelli, L., Piccinni, M. N., Pricolo, F., Salvadeo, S., Montagna, L., Gravina, A., Ferrari, I., Galli, S., Paniga, S., Tinelli, C., & Cicero, A. F. (2006). Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Hypertension. Endothelium, 13(3), 227-231. https://doi.org/10.1080/10623320600780942

Vancouver

Derosa G, D'Angelo A, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo S, et al. Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Hypertension. Endothelium. 2006;13(3):227-231. doi:10.1080/10623320600780942

BibTeX
@article{Derosa2006,
  author = {Derosa, Giuseppe and D'Angelo, Angela and Ciccarelli, Leonardina and Piccinni, Mario N and Pricolo, Fabio and Salvadeo, Sibilla and Montagna, Lorenza and Gravina, Alessia and Ferrari, Ilaria and Galli, Simona and Paniga, Sonia and Tinelli, Carmine and Cicero, Arrigo F G},
  title = {Matrix Metalloproteinase-2, -9, and Tissue Inhibitor of Metalloproteinase-1 in Patients with Hypertension},
  journal = {Endothelium},
  year = {2006},
  volume = {13},
  number = {3},
  pages = {227--231},
  doi = {10.1080/10623320600780942}
}
Kostenlos starten →